Difference between revisions of "Directed Evolution and Synthetic Biology - Hunter Stone"

From GcatWiki
Jump to: navigation, search
(Proteins)
(Directed Evolution and Synthetic Biology)
 
(63 intermediate revisions by 2 users not shown)
Line 1: Line 1:
 
====Project Proposal====
 
====Project Proposal====
  
My project focuses on the use of random mutations to optimize synthetic pathways. Mathematical modeling of synthetic pathways is a powerful, proven tool to maximize product output. However, recently a series of unbiased strategies using recombinant methods have been shown to further increase product yield. These methods, which has been referred to as directed evolution, have produced powerful new methods and approaches for the synthetic biologist.
+
My project focuses on the use of random mutations to optimize synthetic pathways. Mathematical modeling and rational engineering of synthetic pathways is a powerful, proven tool to maximize product output. However, recently a series of unbiased strategies using recombinant methods have been shown to further increase product yield. These methods, which have been referred to as directed evolution, have produced powerful new methods and approaches for the synthetic biologist.
  
==Introduction - Optimization and Directed Evolution==
+
==Introduction - Pathway Optimization and Directed Evolution==
  
Researcher Jay Keasling has recently described a genetically-modified yeast strain that produces artemisinic acid, a chemical precursor to the antimalarial drug artemisinin. In these experiments, his team engineered yeast cells to express enzymes in a pathway that converts farnesyl pyrophosphate (FPP), a metabolic intermediate naturally occurring in yeast, into the desired product. Initially, however, this yeast strain was unable to produce any appreciable amount of artemisin. Keasling’s team had run into a key problem facing many projects in synthetic biology: optimization. Although we are increasingly able to build sophisticated constructs within living cells, the existence of these frameworks does not always correspond with the ability to fulfill their intended purposes efficiently and effectively.
+
Researcher Jay Keasling has recently described a genetically-modified yeast strain that produces artemisinic acid, a chemical precursor to the antimalarial drug artemisinin (Ro, 2006). In these experiments, his team engineered yeast cells to express enzymes in a pathway that converts farnesyl pyrophosphate (FPP), a metabolic intermediate naturally occurring in yeast, into the desired product. Initially, however, this strain was unable to produce any appreciable amount of artemisin . Keasling’s team had run into a key problem facing many projects in synthetic biology: optimization. Although we are increasingly able to express sophisticated constructs within living cells, the existence of these frameworks does not always correspond with the ability to fulfill their intended purposes efficiently and effectively.
  
Keasling’s team chose to address this problem by rationally modifying the metabolism of their yeast strain. Although they were successful in increasing desired product yields, the authors note that further optimization is necessary to meet their goals for cost of production. When one considers the work facing the group in the future, many questions arise. Were the changes they have already made to the yeast’s metabolism truly the best for optimizing artemisinin output? Could changes in other distantly-related metabolic pathways have also helped to increase yields? Are there presently unknown elements in the cell affecting the new pathway which could potentially be changed? Are the enzymes in the new pathway themselves working at maximum efficiency?
+
Keasling’s team chose to address this problem by rationally modifying the metabolism of their yeast strain. Although they were successful in increasing product yields, further optimization was required for them to meet their goals. What would be the best approach to increase product yield in this system? Were the changes the already made to the yeast’s metabolism truly the best for optimizing artemisinin output? Could changes in other distantly-related metabolic pathways have also helped to increase yields? Are there presently unknown elements in the cell affecting the new pathway which could potentially be changed? Are the enzymes in the new pathway themselves working at maximum efficiency?
  
 
One technique with the potential to answer all of these questions is directed evolution.
 
One technique with the potential to answer all of these questions is directed evolution.
  
==The Directed Evolution Method==
+
==Directed Evolution: The Method==
  
 
Directed evolution is a method used to create a more efficient mutant of an existing gene, RNA, pathway or cell. The method follows these general steps:
 
Directed evolution is a method used to create a more efficient mutant of an existing gene, RNA, pathway or cell. The method follows these general steps:
  
# A library of variants of the targeted construct (e.g. a gene, a cell, etc.) is generated through random changes of its genomic DNA. Methods of genetic randomization include error-prone PCR, mutagenic agents like Mutazyme, or random transposon integration.  
+
# A library of variants of the targeted construct (''e.g.'', a gene or a cell) is generated through random changes of its genomic DNA. Methods of genetic randomization include error-prone PCR, mutagenic agents like Mutazyme, or random transposon integration.  
# The variant library goes through a process of screening or selection to reveal the most productive members of the library. Selection and screening techniques are specific to desired function of each experiment (e.g. higher enzyme efficiency, greater cell resistance to ethanol).  
+
# The variant library goes through a process of screening or selection to reveal the most productive members of the library. Selection and screening techniques are specific to desired function of each experiment (''e.g.'' higher enzyme efficiency, greater cell resistance to ethanol).  
 
# The most productive variant is resubmitted to the genetic randomization and selection processes.  
 
# The most productive variant is resubmitted to the genetic randomization and selection processes.  
 
# Steps 1-3 are repeated until the desired result is received - an evolved mutant more adept at the processes it was selected for than its unevolved parent.  
 
# Steps 1-3 are repeated until the desired result is received - an evolved mutant more adept at the processes it was selected for than its unevolved parent.  
Line 22: Line 22:
 
[[Image:DIRECTEDEVOLUTION.jpg]]
 
[[Image:DIRECTEDEVOLUTION.jpg]]
  
The power of directed evolution comes from two sources: its nonbiased nature and its ability probe elements of the cell we either don't know about, like unexplored regions of the genome, or presently lack the capabilities to model and design, like protein structure.
+
==Directed Evolution and Synthetic Biology==
  
For a retrospective review directed evolution, [http://pubs.acs.org/cgi-bin/article.cgi/achre4/1998/31/i03/html/ar960017f.html click here].
+
The power of directed evolution comes from two sources: its nonbiased nature and its ability to test changes in elements of the cell beyond present knowledge and understanding. The method has historically been used to maximize the function of a particular protein. New methods have been developed recently to maximize the function not just of a single protein, but of more complex phenotypes. Using directed evolution to improve both proteins and these more complex phenotypes like enzymatic pathways has tremendous promise for synthetic biology.
  
==Applicability to Synthetic Biology==
+
===Optimization of Enzyme Function===
  
The power of directed evolution comes from two sources: its nonbiased nature and its ability to test changes in elements of the cell beyond present knowledge and understanding. The method has been historically used for the improvement of protein structure, one such region of the cell that is difficult to model and engineer rationally (''reviewed in''). New methods of the technique are also being described which allow for improvement of the studied phenotype based on random changes to the cell genome-wide.
+
Many projects in synthetic biology involve introducing foreign enzymatic pathways into microbes to produce a desired product. Examples include yeast cells engineered to produce atremisinin (Ro ''et al.'', 2006) or microbes engineered to produce fossil fuels ([http://www.amyrisbiotech.com/ Amyris], [http://www.ls9.com/ LS9]). The quantity of output from these pathways ultimately depends on the efficiency of the enzymes introduced. However, rational reengineering of these enzymes is an extremely difficult task due to the complexities of protein structure as well as the lack of sufficient knowledge regarding the relationship between protein structure and funtion.  
  
===Proteins===
+
Two papers describe successful use of directed evolution to improve product yield by augmenting enzymatic function. In both papers, the authors circumvent the laborious task of rational protein engineering by using directed evolution. In addition, the papers describe improvements in genetic randomization and selection to maximize enzyme function.  
 
 
Many synthetic biology projects aimed at product formation involve moving enzymatic pathways from other organisms into microbes. One such example is Jay Keasling's antimalarial drug-producing yeast cells. Another is the current effort of many synthetic biology-based companies like Amyris and LS9 to engineer microbes capable of producing petroleum-like fuels. The efficiency of these synthetically-designed organisms at forming desired products ultimately relies on the efficiency of the individual enzymes in these pathways.
 
 
 
The following two papers describe successful efforts at using directed evolution on enzymes contributing to product formation. Furthermore, both of these papers describe significant improvements in the directed evolution methods. The first, Semi-synthetic DNA shuffling, aims to improve the quality of the randomization steps of directed evolution. The second, A simple method, provides a method for improving the selection steps of directed evolution.
 
  
  
Line 43: Line 39:
 
==="Genome-wide" Directed Evolution===
 
==="Genome-wide" Directed Evolution===
  
 +
A second, emerging branch of directed evolution attempts to improve phenotypes regulated not just by an individual gene but by multiple genes across the entire genome.
  
Directed evolution on proteins has the potential
+
This type of directed evolution provides a method to test changes in many different elements of a cell that make up a system. Attempts at directed evolution on such a scale are relatively new. The following papers describe the use of "genome-wide" directed evolution to improve product yield from complex pathways. So long as improvements can be screened and selected for, these methods might also be applied to improvement and optimization of complex synthetic phenotypes engineered by humans, such as cellular circuitry using an array of [[Logic Gates - Emma Garren|Logic Gates]].
 
 
More recently, new forms of directed evolution have been described that test changes not just in single genes but across the entire genome
 
 
 
There is a long history of using directed evolution to improve protein structure for specific purposes. More recently
 
 
 
don't know about, like unexplored regions of the genome, or presently lack the capabilities to model and design, like protein structure.
 
 
 
  
  
 
+
[[Random Gene Knockout to Maximize Product Yield]]
 
 
 
 
 
 
 
 
 
 
Researchers Hal Alper, Kohei Miyaoku and Greg Stephanopoulos have recently shown the effectiveness of using directed evolution for optimizing a synthetic construct. Previously, the researchers had engineered a strain of ''E. coli'' capable of synthesizing lycopene, a carotenoid which naturally occurs in tomatoes but has more recently been incorporated in vitamin tablets for its antioxidant capabilities. The group was interested in further optimizing the lycopene output of this strain. Using computer modeling, they identified a series of gene knockouts sites which were predicted to increase the lycopene production. However, strains engineered with these knockouts were still unable to produced lycopene at the predicted “stoichiometric maximum.” This finding led the researchers to hypothesize that lycopene production was “limited by unknown kinetic or regulatory factors unaccounted for in the stoichiometric models.”
 
 
 
The researchers used directed evolution to find gene knockouts which might affect these unexplored regions of the cell. A library of lycopene-producing ''E. coli'' with random gene knockout was achieved by introducing genome-wide integrating transposons to the cells ''in vivo'' ('''LINK''').  This random knockout library was then tested through plating, which revealed increases in lycopene production efficiency in the ''E. coli'' as increases in red colony color. The three best knockout ''E. coli'' selected by this screening to determine the beneficial gene knockout sites. All three knockout sites were different from the seven predicted by their models. Two of these knockouts interrupted genes which had been previously undescribed.
 
 
 
The team was interested in determining how effective the three gene knockouts were at increasing lycopene production when compared to the knockouts they had predicting with computer modeling. To answer this question, the researchers created 64 unique strains of the lycopene-producing ''E. coli'' representing all possible combinations of the three knockouts selected by directed evolution, the seven model-predicted knockouts, and the two parental strains from which the “evolved” and model-predicted strains were derived. Lycopene production of the 64 strains was measured by extracting the lycopene from the each colony after and defined time and quantifying lycopene level by absorbance spectroscopy at 475. Of the two global maxima of this experiment, one had a knockout selected through directed evolution testing ('''Fig. 1a'''). Furthermore, this particular knockout strain also showed an earlier peak in lycopene production and when compared to the completely systematically-predicted knockout strain in batch fed culture ('''Fig. 1b''').
 
 
 
[[Image:FIGURE_2_LYCOPENE.jpg]]
 
 
 
(Alper, 2005 - Permission Pending)
 
 
 
'''Figure 1''': The two measurements lycopene production in knockout strains of lycopene producing bacteria. ('''a''') A landscape displaying the 64 strains resulting for all possible combinations of gene knockouts selected through systematic modeling and directed evolution (combinatorial knockouts). Lycopene production for each strain was measured at the end of a 48-h shake-flask fermentation and amount of lycopene produced was quantified through extraction form the cell pellet with acetone and supernatant absorbance at 475 nm. Of interest is global maximum strain Δ''gdhA'' Δ''aceE'' Δ''PyjiD'', which contains a knockout of the Δ''PyjiD'' gene selected through directed evolution testing. ('''b''') Lycopene production of the best knockout strains in batch-fed culture. From left to right, the K12 strain from which combinatorial mutants were derived, the preengineered parental strain from which the systematically-selected knockout strains were derived, global maximum strain Δ''gdhA'' Δ''aceE'' Δ''fdhF'', global maximum strain Δ''gdhA'' Δ''aceE'' Δ''PyjiD'', and the global minimum strain and two local maximum strains from landscape 1a. Of interest is knockout strain Δ''gdhA'' Δ''aceE'' Δ''PyjiD'' (fourth from the left). This strain, which has a gene knockout selected through directed evolution testing, shows the same maximum in lycopene productivity as the entirely systematically-predicted strain Δ''gdhA'' Δ''aceE'' Δ''fdhF'' (third from left), but also shows an earlier peak in this productivity and more sustained lycopene production.
 
 
 
==Weaknesses of the Method==
 
 
 
Although the method of directed evolution is promising to synthetic biology, there are some key weaknesses to this technique. The process of genetic randomization and selection can take long periods of time depending on the construct being used or the trait being selected for. Using slow-growing bacterium or trying to evolve production of compounds that accumulate very slowly can add months to the process. In addition, directed evolution does not always produce evolved mutants significantly more adept at selected functions than their parents. Selective pressure can be difficult to increase in selection tests; in addition, false positives can slip through screening and selection while beneficial mutations can be lost due to the adverse affects they have on the organism unrelated to the function of interest.
 
 
 
==Increases in Sophistication==
 
 
 
Although the concerns addressed in the previous section are very real, new methods of directed evolution have been developed to address these problems and make directed evolution an even more effective process. The following papers describe three new methods for directed evolution aiming to increase the efficiency of the process in different ways.
 
 
 
[[Semi-Synthetic DNA Shuffling and Doramectin]]
 
 
 
[[A Simple Method for Highly Evolved Enzymes]]
 
  
 
[[Global Transcriptome Machinery Engineering]]
 
[[Global Transcriptome Machinery Engineering]]
 
From these papers, we see that directed evolution is a method which has become increasingly modular with different methods of the process that can be employed depending on the nuances of the studied construct.
 
  
 
==Conclusion==
 
==Conclusion==
  
==Figure Bank==
+
Researchers Stutzman-Engwall ''et al.'', Neuenschwander ''et al.'', and Alper ''et al''. have all described successful uses of a general method of engineering called directed evolution to improve desired phenotypes. At no point during these experiments did the researchers draw a model or plan specific changes to genetic code to engineer these phenotypes. Some might say that for this reason directed evolution does not belong within the realm of synythetic biology. At the same time, if synthetic biology is the “engineer’s approach to biology,” then what is an engineer ultimately concerned with except the production of a useful product that meets a need? The research described in the four papers reviewed certainly meets this criterion. Furthermore, the work by Stuzman-Engwall ''et al.'' and Neuenschwander ''et al.'' indicates that directed evolution is, in its own way, becoming an increasingly planned and rational process. Semi-synthetic DNA shuffling allows the researcher to which mutations stay in wheels of genetic randomization and selection, while the “selection vector” described in the work of Neuenschwander et al. allows the researcher to precisely control selective pressure on the enzyme being evolved.
 
 
'''Neuenschwander, M., M. Butz, C. Heintz & D. Hilvert. 2007. A simple selection strategy for evolving highly efficient enzymes. ''Nature Biotechnology'' 25(10): 1145-1147.'''
 
 
 
[[Image:EFFICIENTENZYME.jpg]]
 
 
 
[[Image:efficient_enzyme_data.jpg]]
 
 
 
<small>(Neuenschwander, 2007 - Permission Pending)</small>
 
 
 
'''Stutzman-Engwall, K., S. Conlon, R. Fedechko, H. McArthur, K. Pekrun, Y. Chen, S. Jenne, C. La, N. Trinh, S. Kim, Y. Zhang, R. Fox, C. Gustafsson & A. Krebber. 2005. Semi-synthetic DNA shuffling of ''ave''C leads to improved industrial scale production of doramectin by ''Streptomyces avermitilis''. ''Metabolic Engineering'' 7: 27-37.'''
 
 
 
[[Image:SHUFFLING_SCHEME.jpg]]
 
 
 
<small>(Stemmer, 1994 - Permission Pending)</small>
 
 
 
[[Image:DORAMECTIN2.jpg]]
 
 
 
<small>(Stutzman-Engwall, 2005 - Permission Pending)</small>
 
 
 
 
 
'''Alper, H., J. Moxley, E. Nevoigt, G.R. Fink & G. Stephanopoulos. 2006. Engineering yeast transcription machinery for improved ethanol tolerance and production. ''Science'' 314: 1565-1568.
 
  
[[Image:FIGURE_ETHANOL.jpg]]
+
Perhaps the best strategy is to leave the definitions aside. Alper’s team has shown in lycopene-producing ''E. coli'' that directed evolution can work in concert with traditonal synthetic modeling to meet overaching goals. The two methods appear well suited for one another. Directed evolution cannot be used to engineer new and creative permutations of enzymes like in Jay Keasling’s artemisinic acid-producing yeast; however, as shown in these four papers, the method is an effective way to improve existing systems at multiple levels. On the other hand, while synthetic biology can be used to construct complex biological systems, it is not always apparent to the synthetic biologist why what he or she has engineered does not meet optimal models. Directed evolution provides the synthetic biologist with a way of testing and improving entire systems in a nonbiased manner as they try to make synthetic constructs and optimal model agree.
  
<small>(Alper, 2006 - Permission Pending)</small>
+
As these four papers have shown, when directed evolution is applied to synthetic biology, the two methods work together to create interesting, new, and, most importantly, ''optimally-functioning'' pathways.
  
 
==Works Cited==
 
==Works Cited==

Latest revision as of 16:56, 10 December 2007

Project Proposal

My project focuses on the use of random mutations to optimize synthetic pathways. Mathematical modeling and rational engineering of synthetic pathways is a powerful, proven tool to maximize product output. However, recently a series of unbiased strategies using recombinant methods have been shown to further increase product yield. These methods, which have been referred to as directed evolution, have produced powerful new methods and approaches for the synthetic biologist.

Introduction - Pathway Optimization and Directed Evolution

Researcher Jay Keasling has recently described a genetically-modified yeast strain that produces artemisinic acid, a chemical precursor to the antimalarial drug artemisinin (Ro, 2006). In these experiments, his team engineered yeast cells to express enzymes in a pathway that converts farnesyl pyrophosphate (FPP), a metabolic intermediate naturally occurring in yeast, into the desired product. Initially, however, this strain was unable to produce any appreciable amount of artemisin . Keasling’s team had run into a key problem facing many projects in synthetic biology: optimization. Although we are increasingly able to express sophisticated constructs within living cells, the existence of these frameworks does not always correspond with the ability to fulfill their intended purposes efficiently and effectively.

Keasling’s team chose to address this problem by rationally modifying the metabolism of their yeast strain. Although they were successful in increasing product yields, further optimization was required for them to meet their goals. What would be the best approach to increase product yield in this system? Were the changes the already made to the yeast’s metabolism truly the best for optimizing artemisinin output? Could changes in other distantly-related metabolic pathways have also helped to increase yields? Are there presently unknown elements in the cell affecting the new pathway which could potentially be changed? Are the enzymes in the new pathway themselves working at maximum efficiency?

One technique with the potential to answer all of these questions is directed evolution.

Directed Evolution: The Method

Directed evolution is a method used to create a more efficient mutant of an existing gene, RNA, pathway or cell. The method follows these general steps:

  1. A library of variants of the targeted construct (e.g., a gene or a cell) is generated through random changes of its genomic DNA. Methods of genetic randomization include error-prone PCR, mutagenic agents like Mutazyme, or random transposon integration.
  2. The variant library goes through a process of screening or selection to reveal the most productive members of the library. Selection and screening techniques are specific to desired function of each experiment (e.g. higher enzyme efficiency, greater cell resistance to ethanol).
  3. The most productive variant is resubmitted to the genetic randomization and selection processes.
  4. Steps 1-3 are repeated until the desired result is received - an evolved mutant more adept at the processes it was selected for than its unevolved parent.

DIRECTEDEVOLUTION.jpg

Directed Evolution and Synthetic Biology

The power of directed evolution comes from two sources: its nonbiased nature and its ability to test changes in elements of the cell beyond present knowledge and understanding. The method has historically been used to maximize the function of a particular protein. New methods have been developed recently to maximize the function not just of a single protein, but of more complex phenotypes. Using directed evolution to improve both proteins and these more complex phenotypes like enzymatic pathways has tremendous promise for synthetic biology.

Optimization of Enzyme Function

Many projects in synthetic biology involve introducing foreign enzymatic pathways into microbes to produce a desired product. Examples include yeast cells engineered to produce atremisinin (Ro et al., 2006) or microbes engineered to produce fossil fuels (Amyris, LS9). The quantity of output from these pathways ultimately depends on the efficiency of the enzymes introduced. However, rational reengineering of these enzymes is an extremely difficult task due to the complexities of protein structure as well as the lack of sufficient knowledge regarding the relationship between protein structure and funtion.

Two papers describe successful use of directed evolution to improve product yield by augmenting enzymatic function. In both papers, the authors circumvent the laborious task of rational protein engineering by using directed evolution. In addition, the papers describe improvements in genetic randomization and selection to maximize enzyme function.


Semi-Synthetic DNA Shuffling and Doramectin

A Simple Method for Highly Evolved Enzymes

"Genome-wide" Directed Evolution

A second, emerging branch of directed evolution attempts to improve phenotypes regulated not just by an individual gene but by multiple genes across the entire genome.

This type of directed evolution provides a method to test changes in many different elements of a cell that make up a system. Attempts at directed evolution on such a scale are relatively new. The following papers describe the use of "genome-wide" directed evolution to improve product yield from complex pathways. So long as improvements can be screened and selected for, these methods might also be applied to improvement and optimization of complex synthetic phenotypes engineered by humans, such as cellular circuitry using an array of Logic Gates.


Random Gene Knockout to Maximize Product Yield

Global Transcriptome Machinery Engineering

Conclusion

Researchers Stutzman-Engwall et al., Neuenschwander et al., and Alper et al. have all described successful uses of a general method of engineering called directed evolution to improve desired phenotypes. At no point during these experiments did the researchers draw a model or plan specific changes to genetic code to engineer these phenotypes. Some might say that for this reason directed evolution does not belong within the realm of synythetic biology. At the same time, if synthetic biology is the “engineer’s approach to biology,” then what is an engineer ultimately concerned with except the production of a useful product that meets a need? The research described in the four papers reviewed certainly meets this criterion. Furthermore, the work by Stuzman-Engwall et al. and Neuenschwander et al. indicates that directed evolution is, in its own way, becoming an increasingly planned and rational process. Semi-synthetic DNA shuffling allows the researcher to which mutations stay in wheels of genetic randomization and selection, while the “selection vector” described in the work of Neuenschwander et al. allows the researcher to precisely control selective pressure on the enzyme being evolved.

Perhaps the best strategy is to leave the definitions aside. Alper’s team has shown in lycopene-producing E. coli that directed evolution can work in concert with traditonal synthetic modeling to meet overaching goals. The two methods appear well suited for one another. Directed evolution cannot be used to engineer new and creative permutations of enzymes like in Jay Keasling’s artemisinic acid-producing yeast; however, as shown in these four papers, the method is an effective way to improve existing systems at multiple levels. On the other hand, while synthetic biology can be used to construct complex biological systems, it is not always apparent to the synthetic biologist why what he or she has engineered does not meet optimal models. Directed evolution provides the synthetic biologist with a way of testing and improving entire systems in a nonbiased manner as they try to make synthetic constructs and optimal model agree.

As these four papers have shown, when directed evolution is applied to synthetic biology, the two methods work together to create interesting, new, and, most importantly, optimally-functioning pathways.

Works Cited

Alper, H, K. Miyaoku & G. Stephanopoulos. 2005. Construction of lycopene-overproducing E. coli strains by combining systematic and combinatorial gene knockout targets. Nature Biotechnology 23(5): 612-616.

Alper, H., J. Moxley, E. Nevoigt, G.R. Fink & G. Stephanopoulos. 2006. Engineering yeast transcription machinery for improved ethanol tolerance and production. Science 314: 1565-1568.

Neuenschwander, M., M. Butz, C. Heintz & D. Hilvert. 2007. A simple selection strategy for evolving highly efficient enzymes. Nature Biotechnology 25(10): 1145-1147.

Ro D, E.M. Paradise, M. Ouellet, K.J. Fisher, K.L. Newman, J.M. Ndungu, K.A. Ho, R.A. Eachus, T.S. Ham, J. Kirby, M.C.Y. Chang, S.T. Withers, Y. Shiba, R. Sarpong & J.D. Keasling. 2006. Production of the antimalarial drug precursor artemisinic acid in engineered yeast. Nature 440: 940-43.

Stemmer, W.P.C. 1994. DNA shuffling by random fragmentation and reassembly: in vitro recombination for molecular evolution. PNAS 91: 10747-10751

Stutzman-Engwall, K., S. Conlon, R. Fedechko, H. McArthur, K. Pekrun, Y. Chen, S. Jenne, C. La, N. Trinh, S. Kim, Y. Zhang, R. Fox, C. Gustafsson & A. Krebber. 2005. Semi-synthetic DNA shuffling of aveC leads to improved industrial scale production of doramectin by Streptomyces avermitilis. Metabolic Engineering 7: 27-37.